Nephrectomy improves the survival of metastatic renal cell cancer patients with moderate to good performance status-results from a Finnish nation-wide population-based study from 2005 to 2010.
Lauri LaruHanna RonkainenPasi OhtonenMarkku H VaaralaPublished in: World journal of surgical oncology (2021)
Surgical treatment of metastatic renal cell cancer is associated with a significant survival benefit in patients with good and moderate performance status, regardless of the chosen medical therapy.